Free weekly newsletter
Get the free weekly executive digest
The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Nu Vision Biotherapies Appoints Tim Precious As Chief Executive Officer
PRIVATEMay 26, 2026•23 days ago
Position
Chief Executive Officer
Company
NuVision Biotherapies
NottinghamManufacturingBiotechnologyHealth CareMedical DeviceDescription
NuVision Biotherapies has appointed Tim Precious as chief executive to lead the company’s next phase of growth. Starting on 26 May, Precious will focus on transitioning the business from research and development to a commercially driven organization.
Related People
Suggested for you
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months